Inhibitors | Comment | Organism | Structure |
---|---|---|---|
ppGpp | - |
Staphylococcus aureus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
5'-O-phosphonoadenylyl-(3'->5')-adenosine + H2O | Staphylococcus aureus | - |
2 AMP | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | A0A0H2XFX6 | USA300 | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
5'-O-phosphonoadenylyl-(3'->5')-adenosine + H2O | - |
Staphylococcus aureus | 2 AMP | - |
? | |
additional information | Pde2 is capable of hydrolyzing c-di-AMP, but5 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. No substrate: ATP | Staphylococcus aureus | ? | - |
? | |
additional information | Pde2 is capable of hydrolyzing c-di-AMP, but5 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. No substrate: ATP | Staphylococcus aureus USA300 | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
SAUSA300_1650 | - |
Staphylococcus aureus |
General Information | Comment | Organism |
---|---|---|
physiological function | a Pde2 mutant strain displays a growth defect in the early growth phase. The mutant displays an increase in cellular c-di-AMP and 5'-O-phosphonoadenylyl-(3'->5')-adenosine levels and increased oxacillin resistance. A strain producing a high level of c-di-AMP has increased and a stain producing low levels has decreased acid resistance | Staphylococcus aureus |